Published Date: 28-Jul-2022
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report, published by KBV research, The Global Interventional Oncology Market size is expected to reach $2.9 billion by 2028, rising at a market growth of 6.2% CAGR during the forecast period.
The Lung Cancer segment has shown growth rate of 6.5% during (2022 - 2028). Image-guided lung intervention in oncologic patients includes thermal ablation, transthoracic needle biopsy, fiducial placement, and tunnelled pleural catheter placement, and is enabled by advances in fluoroscopy, computed tomography, and ultrasound technology, and the prevalence of available thermal ablation modalities like microwave, radiofrequency, and cryoablation.
The Embolization Devices segment acquired maximum revenue share in the Global Interventional Oncology Market by Product Type in 2021, thereby, achieving a market value of $1.31 billion by 2028. In the treatment of hepatocellular carcinoma as well as other malignancies with large tumors, such devices are crucial. Embolization devices are also utilized in palliative treatments to help enhance the outcome after liver resection. As a result, the widespread use of these devices in cancer therapy is expected to boost the interventional oncology market growth in the future.
The Ambulatory Surgery Centers segment is showcasing a CAGR of 7.2% during (2022 - 2028). It is due to the growing number of these centers across the world, along with the rise in the investments by the government on the healthcare sector. In addition, these centers are focusing on the specialized medication, which would fuel the growth of the segment during the forecast period.
The North America market dominated the Global Interventional Oncology Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,067.2 million by 2028. The Europe market is estimated to witness a CAGR of 5.8% during (2022 - 2028). Additionally, The Asia Pacific market would experience a CAGR of 6.7% during (2022 - 2028).
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Boston Scientific Corporation, Teleflex, Inc., Cook Medical, Inc. (Cook Group), Medtronic PLC, Terumo Corporation , Johnson & Johnson (Johnson & Johnson Services, Inc.), Becton, Dickinson and Company, AngioDynamics, Inc., Merit Medical Systems, Inc., and HealthTronics, Inc. (Altaris Capital Partners, LLC)
By Cancer Type
By Product Type
By End User
Unique Offerings from KBV Research